Thank you for Subscribing to Healthcare Business Review Weekly Brief
A man with partial facial paralysis underwent months of conventional treatment. Yet one side of his face remained motionless—his smile stuck in a lopsided stillness. Most regenerative clinics would have followed a familiar protocol: an intravenous stem cell infusion. In this method, cells circulate through the bloodstream with the aim of eventually reaching the damaged nerves. At RPT Osaka Clinic, Dr. Hiromichi Nishihara took a different approach. Drawing on decades of surgical experience, he made a bold decision—directly injecting 100 million mesenchymal stem cells (MSCs) into the patient’s facial nerve and ganglion. Within two months, the once-paralyzed muscles began to move. His affected... Read more
Securing the best care is a customer’s singular goal while sifting through healthcare options. With every turn, there are choices to be made—providers to consider, treatments to weigh and plans to compare. Cigna Healthcare (NYSE: CI) makes each step simpler and more empowering through expert guidance and support. A steadfast advocate of better health, Cigna Healthcare offers a comprehensive suite of services that span medical, dental, life and accident insurance alongside... Read more
Sayeed Zia, Director, Finance and Corporate Services, Sydney Children's Hospitals
Natalie Yang, Senior Medical Staff Association Chair, Austin Health
Dr. Christopher Leo, Chairman, Medicine Cluster, Raffles Internal Medicine Centre
Alastair Mah, Vice President of Medical Affairs, United Family Healthcare
Sojan Paul, Manager, Biomedical Engineering & Technology services, Western NSW Local Health District
Whitney Johnson, Clinical Supervisor, and Group Reflective Practice Facilitator, Alfred Health
Bona Fernando, Hospital Director, Mayapada Hospital
Janene Lawrence, Clinical Nurse Manager (Medical), Hutt Valley DHB
Unlocking the Potential of Regenerative Medicine
Reports state that the stem cell regenerative medicine APAC market, valued at $2.86 bn in 2024, is estimated to grow to $10.22 bn by 2029 at a CAGR of 28.9 percent.
A slew of technological and clinical breakthroughs are fueling this growth. Advances in mesenchymal stem cell therapies and induced pluripotent stem cells are expanding treatment possibilities across a wide range of medical conditions, offering new hope for patients with previously untreatable diseases. At the same time, AI-powered analytics are enabling researchers to unlock deeper cellular insights, accelerating discovery and enhancing the precision of regenerative therapies. Tools such as automated bioreactors and 3D bioprinting are streamlining manufacturing workflows and improving the scalability of cell-based treatments.
This edition of Healthcare Business Review APAC highlights recent developments in the stem cell regenerative medicine sector and offers insights into the transformative potential of these therapies. It features thought leadership articles from industry experts, including Whitney Johnson, clinical supervisor and group reflective practice facilitator at Alfred Health, who emphasizes the importance of emotional intelligence in nursing leadership to improve staff well-being, reduce turnover and strengthen healthcare delivery. Colin Baker, director of medical imaging and pathology contracts at Western Health, discusses the importance of team leadership in healthcare, focusing on collaboration across different disciplines to achieve the best patient outcomes.
The magazine also spotlights leading companies like RPT Osaka Clinic, which offers advanced mesenchymal stem cell therapy and immunotherapy for neurodegenerative, autoimmune and degenerative conditions. Holding Japan’s highest record of stem cell treatments, it prioritizes ethical, science-driven care to restore health and enhance quality of life.
We hope this edition provides valuable insights into how innovation, cutting-edge research and strategic implementation are setting new standards in the field of stem cell regenerative medicine.